Ad
Tuesday, 25 April 2017
Japan's Otsuka aims to apply for TB drug approval in India in 90 days
MUMBAI (Reuters) - Japanese drugmaker Otsuka Pharmaceutical aims to apply for approval of its tuberculosis (TB) drug delamanid in India within three months, a senior company official said, as calls grow for expanded access to the life-saving medicine.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment